BioNJ's 5th Annual CEO Summit
BioNJ's 5th Annual CEO Summit will bring together life sciences C-suite leaders and their teams -- representing a wide breadth of companies from early to late stage, as well as public, private, revenue and pre-revenue enterprises -- for a full-day program focused on the opportunities and challenges facing the future of medical innovation. You'll hear from thought leaders including Mark Alles, CEO, Celgene; Albert Bourla, Group President, Pfizer Innovative Health, Pfizer Inc.; Dr. Elizabeth Fowler, Vice President, Global Health Policy, Johnson & Johnson; James Greenwood, President & CEO, BIO; Paris Panayiotopoulos, Former President & CEO, ARIAD Pharmaceuticals; Paul Hudson, CEO, Novartis; Dr. Clive Meanwell, CEO, The Medicines Company and Brent Saunders, Chairman & CEO, Allergan.
Date and Time
Friday Oct 27, 2017
7:00 AM - 4:00 PM EDT
Friday, October 27, 2017 7:00 a.m. - 4:00 p.m.
Location
Bridgewater Marriott 700 Commons Way Bridgewater, NJ 08807
Fees/Admission
Registration for the event is $595 for Members of BioNJ and affiliated organizations and $795 for future BioNJ Members. Contact Edie Esposito at EEsposito@BioNJ.org to learn about Sponsorship opportunities and place your company in the spotlight.
Contact Information
Debbie Mennito
DMennito@BioNJ.org
(609) 890-3185
Send Email
